AusPAR: Zeposia | Therapeutic Goods Administration (TGA)

AusPAR

AusPAR: Zeposia [PDF, 637.38 KB]

AusPAR: Zeposia [Word, 674 KB]

AusPAR Attachment 1: Product Information for Zeposia [PDF, 382.51 KB]

AusPAR Attachment 1: Product Information for Zeposia [Word, 165.12 KB]

Device/Product Name

Zeposia

Active ingredients

Ozanimod

AusPAR Date

8 September 2022

Published

20 September 2022

Submission Number

PM-2021-00444-1-1

Submission Type

Extension of indications

Decision

Approved